Simplex Trading’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $57 | Buy |
69,900
+37,800
| +118% | +$3.89M | ﹤0.01% | 8899 |
|
|
2025
Q4 | $3.26M | Sell |
32,100
-73,100
| -69% | -$5.87M | ﹤0.01% | 1591 |
|
|
2025
Q3 | $5.75M | Buy |
105,200
+39,100
| +59% | +$1.95M | ﹤0.01% | 1338 |
|
|
2025
Q2 | $3.51M | Sell |
66,100
-62,400
| -49% | -$3.17M | ﹤0.01% | 1643 |
|
|
2025
Q1 | $5.56M | Sell |
128,500
-17,100
| -12% | -$866K | ﹤0.01% | 1243 |
|
|
2024
Q4 | $8.18M | Sell |
145,600
-57,600
| -28% | -$3.58M | ﹤0.01% | 1157 |
|
|
2024
Q3 | $13.8M | Buy |
203,200
+100,600
| +98% | +$5.68M | 0.01% | 836 |
|
|
2024
Q2 | $4.33M | Sell |
102,600
-143,600
| -58% | -$7.9M | ﹤0.01% | 1534 |
|
|
2024
Q1 | $17M | Buy |
246,200
+103,000
| +72% | +$6.52M | 0.01% | 799 |
|
|
2023
Q4 | $10.6M | Buy |
143,200
+26,300
| +22% | +$1.72M | 0.01% | 1046 |
|
|
2023
Q3 | $7.97M | Sell |
116,900
-31,800
| -21% | -$2.7M | 0.01% | 1040 |
|
|
2023
Q2 | $14M | Buy |
148,700
+23,000
| +18% | +$1.79M | 0.01% | 722 |
|
|
2023
Q1 | $8.52M | Sell |
125,700
-137,600
| -52% | -$8.84M | 0.01% | 985 |
|
|
2022
Q4 | $13M | Buy |
263,300
+87,000
| +49% | +$3.55M | 0.01% | 733 |
|
|
2022
Q3 | $5.73M | Sell |
176,300
-4,900
| -3% | -$202K | 0.01% | 1106 |
|
|
2022
Q2 | $7.14M | Buy |
181,200
+36,600
| +25% | +$1.96M | 0.01% | 945 |
|
|
2022
Q1 | $10.1M | Sell |
144,600
-4,600
| -3% | -$336K | 0.01% | 835 |
|
|
2021
Q4 | $11.6M | Buy |
149,200
+40,200
| +37% | +$3.55M | 0.01% | 716 |
|
|
2021
Q3 | $13.5M | Buy |
109,000
+100
| +0.1% | +$10.6K | 0.01% | 591 |
|
|
2021
Q2 | $13.5M | Buy |
108,900
+108,066
| +12,958% | +$12.9M | 0.01% | 585 |
|
|
2021
Q1 | $11M | Buy |
+834
| New | +$114K | 0.02% | 435 |
|
|
2020
Q4 | – | Sell |
-959
| Closed | -$9.78M | – | 8536 |
|
|
2020
Q3 | $9.78M | Buy |
959
+238
| +33% | +$20.6K | 0.01% | 516 |
|
|
2020
Q2 | $6.27M | Sell |
721
-874
| -55% | -$69.8K | 0.01% | 722 |
|
|
2020
Q1 | $9.25M | Buy |
+1,595
| New | +$129K | 0.02% | 451 |
|
|
2019
Q4 | – | Sell |
-845
| Closed | -$7.64M | – | 7453 |
|
|
2019
Q3 | $7.64M | Buy |
845
+352
| +71% | +$40.1K | 0.02% | 507 |
|
|
2019
Q2 | $5.82M | Buy |
493
+69
| +16% | +$6.95K | 0.02% | 607 |
|
|
2019
Q1 | $3.67M | Sell |
424
-1,035
| -71% | -$88.1K | 0.01% | 897 |
|
|
2018
Q4 | $9.21M | Buy |
1,459
+308
| +27% | +$21.1K | 0.03% | 362 |
|
|
2018
Q3 | $9.08M | Buy |
1,151
+696
| +153% | +$45.4K | 0.03% | 399 |
|
|
2018
Q2 | $2.72M | Sell |
455
-86
| -16% | -$4.63K | 0.01% | 928 |
|
|
2018
Q1 | $146K | Sell |
541
-25
| -4% | -$1.22K | 0.01% | 1487 |
|
|
2017
Q4 | $981K | Sell |
566
-108
| -16% | -$5.77K | 0.04% | 408 |
|
|
2017
Q3 | $569K | Buy |
674
+279
| +71% | +$11.2K | 0.02% | 602 |
|
|
2017
Q2 | $334K | Sell |
395
-535
| -58% | -$16.5K | 0.01% | 883 |
|
|
2017
Q1 | $395K | Buy |
930
+66
| +8% | +$1.31K | 0.02% | 809 |
|
|
2016
Q4 | $196K | Buy |
864
+280
| +48% | +$4.52K | 0.01% | 1070 |
|
|
2016
Q3 | $292K | Sell |
584
-481
| -45% | -$8.48K | 0.02% | 795 |
|
|
2016
Q2 | $203K | Buy |
1,065
+757
| +246% | +$5.7K | 0.01% | 979 |
|
|
2016
Q1 | $12K | Sell |
308
-23
| -7% | -$147 | ﹤0.01% | 3292 |
|
|
2015
Q4 | $24K | Sell |
331
-447
| -57% | -$4.16K | ﹤0.01% | 2534 |
|
|
2015
Q3 | $241K | Buy |
778
+342
| +78% | +$7.86K | 0.02% | 802 |
|
|
2015
Q2 | $508K | Buy |
436
+228
| +110% | +$5.73K | 0.04% | 390 |
|
|
2015
Q1 | $162K | Sell |
208
-49
| -19% | -$1.24K | 0.02% | 819 |
|
|
2014
Q4 | $248K | Buy |
+257
| New | +$6.25K | 0.03% | 504 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Simplex Trading's EXAS Position: Q1 2026 in Review
Simplex Trading sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 22,521 shares — an estimated $2.32M sold.
Simplex Trading first reported a position in EXAS in Q1 2016 and held it in 24 quarters. The position peaked at $8.14M in Q1 2024. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Simplex Trading reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 22,521 Exact Sciences shares in Q1 2026, an estimated $2.32M.
- Simplex Trading first reported a position in Exact Sciences in Q1 2016 and held it in 24 quarters.
- Simplex Trading's Exact Sciences position peaked at $8.14M in Q1 2024.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.